ADVENT at IRS-ISIAN | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission
Join Profs. Shigeharu Fujieda, Peter Hellings, and Eugenio De Corso for an educational symposium on the evolving understanding of disease control and clinical remission in CRSwNP.
Learning objectives
- Identify hallmarks of disease control in CRSwNP
- Set appropriate goals beyond symptom control for patients with CRSwNP
- Evaluate recently published definitions of remission in CRSwNP with an eye toward improving patient outcomes
Description
Join Professors Shigeharu Fujieda, MD, PhD, Peter Hellings, MD, PhD, and Eugenio De Corso, MD, PhD, as they consider the evolving understanding of disease control and clinical remission in CRSwNP. The panel will discuss hallmarks of disease control, recent consensus publications defining what remission means for patients with CRSwNP, and real-world perspectives on the potential for achieving remission with available biologic therapies.
Agenda
Welcome and Introductions
Guideline Definitions of Control in CRSwNP
Emerging Expert Definitions of Remission in CRSwNP
Eugenio De Corso
Remission in CRSwNP: A Real-World Perspective
Panel Discussion: From Concept to Clinic: The Benefits of Pursuing Remission and the Key Components for Providers and Patients
Discussion/Q&A
This event is co-sponsored between ISIAN & IRS 2024 and Sanofi and Regeneron. The speakers are being compensated and/or receiving honoraria from Sanofi and Regeneron in connection with this program.
Location
Speakers
